Clinical Trial

Journavx to Treat Pain After Thumb Basal Joint Arthroplasty

Name: Journavx to Treat Pain After Thumb Basal Joint Arthroplasty — clinical trial record (NCT07723352)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Enrolling by Invitation

View on ClinicalTrials.gov →

Summary

The purpose of this study is to find out how well suzetrigine, a newly FDA-approved non-opioid pain medication, works to relieve pain after thumb basal joint replacement surgery. The researchers believe that suzetrigine may provide effective pain relief during recovery without the use of opioid medications.

Trial Details

NCT Number	NCT07723352
Lead Sponsor	Rothman Institute Orthopaedics
Conditions	Thumb Basal Joint Osteoarthritis, Postoperative Pain, Joint Replacement Surgery, Joint Replacement
Enrollment	100 participants
Start Date	2026-07-21
Primary Completion	2028-12-31 (estimated)
Study Completion	2028-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-07-23